Sunday, May 24, 2015

GeneNews in pact to increase stake in IDL venture

GeneNews in pact to increase stake in IDL venture

May 19, 2015 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has entered into a purchase agreement with Cobalt Healthcare Consultants to purchase Health Diagnostic Laboratory’s (HDL) one-third ownership stake in their Innovative Diagnostic Laboratory (IDL) joint venture for $4-million. Combined with prior investments in IDL, GeneNews and Cobalt will each own a 50% equity interest in the joint venture. GeneNews and Cobalt […]

GeneNews IDL JV test volume up 150% in Q1

GeneNews IDL JV test volume up 150% in Q1

May 14, 2015 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) U.S. joint venture, Innovative Diagnostic Laboratory (IDL), carried out a total of 39,500 tests in the first quarter this year, up about 150%, from 15,800 in the year earlier quarter. In a statement, James Howard-Tripp, executive chairman of GeneNews, said that with vital functions at IDL successfully brought in-house, “we remain committed […]

GeneNews IDL JV processed 150,000 tests in 2014

GeneNews IDL JV processed 150,000 tests in 2014

April 1, 2015 by · Leave a Comment 

Tweet Despite changes GeneNews (TSX:GEN) carried out to the overall operations and sales force at its Innovative Diagnostic Laboratory (IDL) joint venture, total test volumes were 97,400 in second half of 2014, up approximately 50% from 65,700 in the first half of the year. “In many respects, we only just crossed the starting line at […]

Study finds colorectal cancer in young patients to double

Study finds colorectal cancer in young patients to double

November 17, 2014 by · Leave a Comment 

Tweet In the next 15 years, more than one-in-10 colon cancers and nearly one-in-four rectal cancers will be diagnosed in patients younger than the traditional screening age, according to researchers at The University of Texas MD Anderson Cancer Center. The growing public health problem is underscored by data trends among 20- to 34-year-olds in the […]

GeneNews’ IDL JV lab tests climb in Q3

GeneNews’ IDL JV lab tests climb in Q3

November 12, 2014 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) U.S. joint venture, Innovative Diagnostic Laboratory, processed more than 50,600 tests during the third quarter this year. With a successful limited scale launch of IDL’s operations in the fourth quarter of 2013, full scale up activities began in the first quarter this year, including growing IDL’s lab capacity, increasing the size and […]

GeneNews Q2 JV lab test volumes more than triple sequentially

GeneNews Q2 JV lab test volumes more than triple sequentially

August 8, 2014 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) U.S. joint venture, Innovative Diagnostic Laboratory (IDL), processed 46,051 tests in the second quarter, up more than threefold sequentially from the 14,680 tests processed in the first quarter this year. “So far, that growth has continued into the third quarter,” GeneNews executive chairman James Howard-Tripp said in a statement. IDL’s menu of […]

GeneNews’ IDL jv highlighted on CEO Clips

GeneNews’ IDL jv highlighted on CEO Clips

July 3, 2014 by · Leave a Comment 

Tweet James Howard-Tripp, executive chairman of GeneNews (TSX:GEN), has been featured on Business Television’s CEO Clips discussing the company’s new U.S. joint venture, Innovative Diagnostic Laboratory, or IDL. IDL’s mission is to provide a comprehensive menu of advanced blood tests that aid in early cancer detection, guide cancer treatment protocols, and monitor remission and recurrence. […]

GeneNews in $7.2-million private placement

GeneNews in $7.2-million private placement

July 2, 2014 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) is proposing to complete a non-brokered private placement of up to seven million new common shares at a price of $1.03 a share (a 12.5% discount to the five-day VWAP) for gross proceeds of up to $7.2-million. Proceeds will be used for general working capital purposes. Closing is set for July 7. […]

PHI test included in updated NCCN Guidelines

PHI test included in updated NCCN Guidelines

May 23, 2014 by · Leave a Comment 

Tweet Beckman Coulter’s Prostate Health Index (PHI), which is offered in the U.S. by GeneNews’ (TSX:GEN) Innovation Diagnostic Lab (IDL) joint venture, has been recommended by the National Comprehensive Cancer Network (NCCN) as a blood test to improve specificity for prostate cancer detection in its recently updated Clinical Practice Guidelines in Oncology (NCCN Guidelines) for […]

GeneNews’ IDL off to flying start

GeneNews’ IDL off to flying start

May 20, 2014 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) recently formed U.S. joint venture, Innovative Diagnostic Laboratory (IDL), took a huge step forward in the first quarter in its goal of becoming a leader in molecular diagnostics and personalized medicine. “With a successful limited scale launch of IDL in the fourth quarter of 2013, full scale-up activities began in the first […]

Next Page »

Email Newsletters with Constant Contact
Google+